Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bukowski

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Cancer Research|January 15, 1994
Estrogen receptor mutations in tamoxifen-resistant breast cancerP S Karnik, S Kulkarni, X P Liu, et al.
Investigational New Drugs|January 1, 1986
Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factorG T Budd, M J Schreiber, E Steiger, et al.
Cancer Treatment Reports|May 1, 1983
Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot studyC D Haas, C M Mansfield, L P Leichman, et al.
Seminars in Oncology|May 29, 1999
Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostineG T Budd, R Ganapathi, L Wood, et al.
American Journal of Clinical Oncology|October 1, 1982
Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot studyA Theodors, R M Bukowski, J S Hewlett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase-I trial of UltrapureTM human leukocyte interferon in human malignancyG T Budd, R M Bukowski, L Miketo, et al.
AIDS Patient Care and Stds|October 1, 1996
HIV infection among Brazilian transvestites in a prison populationD Varella, L Tuason, M R Proffitt, et al.
British Journal of Cancer|June 16, 2005
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinomaR M Gemmill, M Zhou, L Costa, et al.
Medical and Pediatric Oncology|January 1, 1982
Hepatic artery infusion with 5-fluorouracil and mitomycin-C in metastatic colorectal carcinoma phase II studyA Theodors, R M Bukowski, I Lavery, et al.
Lancet (London, England)|October 25, 1980
Prostacyclin therapy of thrombotic thrombocytopenic purpuraG T Budd, R M Bukowski, F V Lucas, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Cancer Research|January 15, 1994
Estrogen receptor mutations in tamoxifen-resistant breast cancerP S Karnik, S Kulkarni, X P Liu, et al.
Investigational New Drugs|January 1, 1986
Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factorG T Budd, M J Schreiber, E Steiger, et al.
Cancer Treatment Reports|May 1, 1983
Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot studyC D Haas, C M Mansfield, L P Leichman, et al.
Seminars in Oncology|May 29, 1999
Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostineG T Budd, R Ganapathi, L Wood, et al.
American Journal of Clinical Oncology|October 1, 1982
Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot studyA Theodors, R M Bukowski, J S Hewlett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase-I trial of UltrapureTM human leukocyte interferon in human malignancyG T Budd, R M Bukowski, L Miketo, et al.
AIDS Patient Care and Stds|October 1, 1996
HIV infection among Brazilian transvestites in a prison populationD Varella, L Tuason, M R Proffitt, et al.
British Journal of Cancer|June 16, 2005
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinomaR M Gemmill, M Zhou, L Costa, et al.
Medical and Pediatric Oncology|January 1, 1982
Hepatic artery infusion with 5-fluorouracil and mitomycin-C in metastatic colorectal carcinoma phase II studyA Theodors, R M Bukowski, I Lavery, et al.
Lancet (London, England)|October 25, 1980
Prostacyclin therapy of thrombotic thrombocytopenic purpuraG T Budd, R M Bukowski, F V Lucas, et al.
Pageof 17